ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

GMDA Gamida Cell Ltd

0.0327
0.00 (0.00%)
Last Updated: 20:00:00
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Gamida Cell Ltd GMDA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 0.0327 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.0327
more quote information »

Recent News

Date Time Source Heading
4/08/202407:30GLOBEXORTX Welcomes New Member to the Board of Directors
4/01/202408:00GLOBEAquestive Therapeutics Strengthens Board of Directors with..
3/27/202406:57IHMARKETNEWSU.S. Stock Index Futures Point to a Rebound, Oil See..
2/14/202414:14EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/02/202416:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202416:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202416:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202416:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202416:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/29/202406:31EDGAR2Form 8-K - Current report
1/08/202407:00EDGAR2Form 8-K - Current report
12/18/202306:28EDGAR2Form 8-K - Current report
12/15/202300:15EDGAR2Form EFFECT - Notice of Effectiveness
12/06/202317:24EDGAR2Form S-3/A - Registration statement under Securities Act of..
11/24/202316:15EDGAR2Form 8-K - Current report
11/20/202317:27EDGAR2Form SC 13D/A - General statement of acquisition of..
11/15/202317:24EDGAR2Form S-3 - Registration statement under Securities Act of..
11/15/202307:00EDGAR2Form 8-K - Current report
11/14/202307:00GLOBEGamida Cell Reports Third Quarter 2023 Financial Results and..
11/08/202316:05EDGAR2Form SC 13D/A - General statement of acquisition of..
10/20/202316:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/20/202316:01EDGAR2Form 8-K - Current report
10/11/202307:07EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
10/02/202316:01EDGAR2Form SC 13D/A - General statement of acquisition of..
9/29/202308:41EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
9/27/202316:43EDGAR2Form 8-K - Current report
9/13/202316:01EDGAR2Form DEF 14A - Other definitive proxy statements
9/01/202316:08EDGAR2Form PRE 14A - Other preliminary proxy statements
8/21/202317:00EDGAR2Form SC 13D - General statement of acquisition of beneficial..
8/15/202316:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/15/202316:11EDGAR2Form 3 - Initial statement of beneficial ownership of..
8/14/202316:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/14/202307:30EDGAR2Form 8-K - Current report
7/11/202308:00BWData Published in Transplantation and Cellular Therapy..
7/10/202314:00PRNUSSTAND UP TO CANCER NAMES JULIAN ADAMS, Ph.D., CHIEF SCIENCE..
6/14/202316:30BWGamida Cell To Host Investor Day
5/31/202316:30BWGamida Cell to Present Corporate Highlights at the Jefferies..
5/31/202307:00BWData To Be Presented on Gamida Cell Natural Killer (NK) Cell..
5/22/202308:00BWGamida Cell Appoints Terry Coelho as CFO
5/15/202316:05BWGamida Cell Reports First Quarter 2023 Financial Results and..
5/11/202317:20BWGamida Cell Announces the Date of Its First Quarter 2023..
4/19/202308:15BWGamida Cell Announces Pricing of $23 Million Public Offering..
4/18/202319:16BWGamida Cell Announces Launch of Public Offering of..
4/17/202316:16BWGamida Cell’s Allogeneic Cell Therapy Omisirge®..
4/17/202314:30DJNGamida Cell Shares Up 34% on FDA Approval of Omisirge Cell..

Your Recent History

Delayed Upgrade Clock